for HD Chorea in Adults

Go about
your day
with reduced
uncontrollable movements

People taking AUSTEDO® (deutetrabenazine) tablets saw

With AUSTEDO XR there was more than twice the reduction in Huntington’s Disease vs placebo in 12 weeks compared to placebo

in Huntington’s disease (HD) chorea
vs placebo in a 12-week study*

*4.4-point improvement in people taking AUSTEDO vs 1.9 in people taking placebo based on Total Maximal Chorea (TMC) score. The TMC score is used to measure HD chorea movements in the face, mouth, trunk, both arms, and both legs.

9 out of 10 people on AUSTEDO XR said their movement control had improved since starting treatment

said their movement control had improved since starting treatment

Results from a real-world survey including 31 patients with HD chorea taking AUSTEDO XR.

Established safety results for

ESTABLISHED SAFETY RESULTS FOR ABOUT 3 YEARS

This was an open-label study, which is a drug trial in which all participants are aware of the drug being tested.

In clinical trials

93% of adults continued taking AUSTEDO XR without needing to reduce their dose due to side effects

continued taking AUSTEDO without
needing to reduce their dose due to side effects

Once-daily AUSTEDO XR contains the same active
ingredient as twice-daily AUSTEDO. Data on this page is
based on twice-daily dosing.

51 percent of HD patients on Austedo saw treatment success. 42 percent of doctors saw treatment success.

People reported improvement in HD chorea symptoms

People with HD chorea on AUSTEDO rated symptoms as “very much improved” or “much improved” at 12 weeks with AUSTEDO.

§Treatment success is measured by perceived improvement in TMC score.

51 percent of Huntington’s Disease patients on Austedo saw treatment success

People taking AUSTEDO XR were more physically capable of performing everyday tasks.

  • Climbing stairs
  • Bending, kneeling, or stooping
  • Lifting/carrying groceries
  • Walking
  • Dressing
  • Bathing
  • Moderate to vigorous activities
People taking AUSTEDO XR were more physically capable of performing everyday tasks

People taking AUSTEDO achieved greater improvement in the SF-36 Physical Functioning Score at 12 weeks vs placebo.

See study details

SF-36=36-Item Short Form Health Survey assessing health-related quality of life.

AUSTEDO XR/AUSTEDO does not cure the
cause of the uncontrollable movements and it does
not treat the other symptoms of HD, such
as problems with thinking or emotions.

See why Ray and Rhonda made the decision to treat HD chorea.

See why Ray and Rhonda made the decision to treat HD chorea

When HD chorea threatened to disrupt Ray and Rhonda's retirement plans, they knew it was time to ask Ray's healthcare provider about treatment options.

About HD chorea

Chorea is one of the most visible
symptoms of
HD, but it can be treated.

Learn more

Start the
conversation now

Whether you're starting to plan ahead or
considering medication,
using the Appointment Preparation Guide to talk to a healthcare

provider is an important step.

Get the guide